TMG to provide PACS consulting to AmeriNet

Article

Technology Marketing Group has signed a three-year contract with AmeriNet to provide the healthcare purchasing organization with research and consulting services in diagnostic imaging and PACS. St. Louis-based AmeriNet represents 14,750 hospitals,

Technology Marketing Group has signed a three-year contract with AmeriNet to provide the healthcare purchasing organization with research and consulting services in diagnostic imaging and PACS.

St. Louis-based AmeriNet represents 14,750 hospitals, medical groups, nursing homes, surgery centers, managed-care organizations, pharmacies, and integrated delivery networks in all 50 states. TMG specializes in technology marketing research, with an emphasis on medical imaging. It has recently begun assisting hospitals with planning for digital image management and PACS projects.

TMG will offer AmeriNet member facilities PACS education seminars, imaging operations assessment programs, benchmark reports comparing imaging centers’ operations and performance to regional and national data, and development of site-specific quality assurance programs.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.